Literature DB >> 3332047

Wilson's disease.

C D Marsden1.   

Abstract

Entities:  

Mesh：

Year:  1987        PMID： 3332047

Source DB:  PubMed          Journal:  Q J Med        ISSN： 0033-5622


× No keyword cloud information.
  18 in total

1.  Effects of long-term treatment in Wilson's disease with D-penicillamine and zinc sulphate.

Authors:  A Czlonkowska; J Gajda; M Rodo
Journal:  J Neurol       Date:  1996-03       Impact factor: 4.849

2.  Wilson's disease in Scotland.

Authors:  R H Park; P McCabe; G S Fell; R I Russell
Journal:  Gut       Date:  1991-12       Impact factor: 23.059

Review 3.  Neuroimaging in Wilson disease.

Authors:  H N van Wassenaer-van Hall
Journal:  Metab Brain Dis       Date:  1997-03       Impact factor: 3.584

Review 4.  Clinical presentations of Wilson disease.

Authors:  Samuel Shribman; Thomas T Warner; James S Dooley
Journal:  Ann Transl Med       Date:  2019-04

Review 5.  Neurologic impairment in Wilson disease.

Authors:  Petr Dusek; Tomasz Litwin; Anna Członkowska
Journal:  Ann Transl Med       Date:  2019-04

Review 6.  Classification and differential diagnosis of Wilson's disease.

Authors:  Wieland Hermann
Journal:  Ann Transl Med       Date:  2019-04

7.  Effects of interactions between drugs on the renal excretion of trientine in rats--acetazolamide and furosemide increase trientine excretion.

Authors:  M Kobayashi; H Fujisaki; M Sugawara; K Iseki; K Miyazaki
Journal:  Pharm Res       Date:  1999-12       Impact factor: 4.200

8.  WILSON'S DISEASE (A report of two cases).

Authors:  M Kanitkar; S N JOSHi; N Dutta Roy
Journal:  Med J Armed Forces India       Date:  2017-06-27

9.  [Electrophysiological impairment profile of patients with Wilson's disease].

Authors:  W Hermann; T Villmann; A Wagner
Journal:  Nervenarzt       Date:  2003-10       Impact factor: 1.214

10.  Fine motor skills disorders in the course of Wilson's disease.

Authors:  Peter Albrecht Günther; Hans-Juergen Kühn; Thomas Villmann; Wieland Hermann
Journal:  Ann Indian Acad Neurol       Date:  2009-01       Impact factor: 1.383
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.